Frontlight ResearchEarly access
Trial site
Raffi Tachdjian MD, Inc.
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Asthma1 trial
- Chronic spontaneous urticaria1 trial
- Phase
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Celldex Therapeutics1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Active, not recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Site data: ClinicalTrials.govUpdated 15 Nov 2026